Contact

Please use this form to send email to PR contact of this press release:
Genekam entwickelt ein Powermolekül, dass Coronaviren und Mutationen (Delta und Omikron) ohne Nebenwirkungen verhindert

TO:
Stephan Suppers
Genekam Biotechnology AG
+49 203 5558580

FROM:
Your Name:
Your Email:	Please check your email address!
Subject:
Message:
Confirmation code:	Please, do not fill this field.
Confirmation version code:	Please, do not change this field.
Javascript data:	Please, do not fill if your javascript is turned off.
Please type in the code you see in the image. Or click Send Email to generate another image instead.
	SEND EMAIL